Comprehensive Cancer Centers of Nevada   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Henderson NV United States (1974)

Organization Overview

First Clinical Trial
2004
NCT00630747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Oscar Goodman, Jr. | Wolfram Samlowski

Active Ingredients

Drugs in Phase 3 Trials (1)

idursulfase (elaprase) (1 trial)

Drugs in Phase 2 Trials (2)

dovitinib (1 trial)

ipilimumab (yervoy) (1 trial)

Drugs in Phase 1 Trials (3)

docetaxel (taxotere) (1 trial)

lb-100 (1 trial)

xmt-1001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Lung Neoplasms (Phase 1)

Melanoma (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Prostatic Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 1)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6